2011
DOI: 10.1016/j.mpmed.2011.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Assessment and initial management of acute kidney injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…It was identified a prevalence of patients with elevation in ALP and AAT levels (12.8%) and urea and creatinine levels (21.3%), these elevations show that the animals may present different degrees of renal and hepatic impairment, occurring due to deposition of immunocomplexes in glomerulus (Kumar & Saxena, 2018). A drop in perfusion occurs due to hypovolemia and systemic hypotension, as well as, by lesion in hepatocytes caused by endotoxemia and/or reduced circulation in the liver from dehydration (Feldman & Nelson, 1996;Nunes et al, 2010;Griffiths & Kanagasundaram, 2011;Honório et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…It was identified a prevalence of patients with elevation in ALP and AAT levels (12.8%) and urea and creatinine levels (21.3%), these elevations show that the animals may present different degrees of renal and hepatic impairment, occurring due to deposition of immunocomplexes in glomerulus (Kumar & Saxena, 2018). A drop in perfusion occurs due to hypovolemia and systemic hypotension, as well as, by lesion in hepatocytes caused by endotoxemia and/or reduced circulation in the liver from dehydration (Feldman & Nelson, 1996;Nunes et al, 2010;Griffiths & Kanagasundaram, 2011;Honório et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…It has also been suggested that the strict definition of AKI requires the correction of pre-renal azotaemia 5 -the reduction in renal excretory capacity arising from renal under-perfusion. 6 Pre-renal azotaemia is a predictable by-product of a normal, physiological response to reduced effective circulating volume and is readily reversed through volume replacement or vasopressor therapy as no renal cell injury (i.e. AKI) has yet occurred.…”
Section: Discussionmentioning
confidence: 99%
“…1 Patients with one or more risk factors should undergo frequent biochemical monitoring and clinical review of fluid balance, volume status and medications. 15 Clinicians often view the management of AKI as challenging because of its perceived complexity. However, studies have demonstrated that, all too often, even the basics in care (such as fluid balance, intravenous fluids and regular blood monitoring) are neglected.…”
Section: Epidemiologymentioning
confidence: 99%